AQST
USDAquestive Therapeutics Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$6.410
Hoch
$6.410
Tief
$5.790
Volumen
3.85M
Unternehmensfundamentaldaten
Marktkapitalisierung
736.9M
Branche
Drug Manufacturers - Specialty & Generic
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
3.10M
Börse
NGM
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company's ongoing development initiatives Matthew Davis, M.D.,
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
WARREN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
WARREN, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
WARREN, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Ähnliche Aktien
IPDN
Professional Diversity Network Inc.
HIG
Hartford Financial Services Group Inc. (The)
BYSI
BeyondSpring Inc. Ordinary Shares
TRONW
Corner Growth Acquisition Corp. 2 Warrants
BCTXW
BriaCell Therapeutics Corp. Warrant
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.